Clinical Trial Update: Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line Treatment [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is evaluating sulfasalazine added to intensive chemotherapy as first-line treatment for elderly patients with acute myeloid leu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING